Reproduction · 2017 · 40 citations · 24 references
Life SciencesMolecular BiologyMolecular GeneticsCell SignalingGene ExpressionSignal TransductionExtracellular MatrixFibrosisUterine FibroidsUterine PathologyWnt SignalingCanonical Beta-catenin SignalingCanonical Wnt Beta-catenin PathwayCanonical Wnt PathwayCanonical Wnt SignalingMutations In Wnt Signaling PathwayWestern BlottingWnt Signal TransductionWnt Signaling Disruption
Abstract Recent studies showed that genetic aberrations in the MED12 gene, probably through the canonical WNT/β-catenin pathway, lead to the pathogenesis of uterine fibroids. However, a comprehensive analysis of the WNT pathway in MED12-mutated and MED12-wild-type fibroids has not been performed. The objective of this study was to determine the status of the WNT pathway in human fibroids. We performed Sanger sequencing to define the MED12 mutational status of fibroids and normal myometrium samples. qPCR arrays were carried out to determine the status of the WNT signaling pathway in MED12-mutated and MED12-wild-type fibroids. Liquid chromatography–mass spectrometry (LC–MS), Western blotting and immunohistochemistry were used to monitor the expression of β-catenin. We showed that β-catenin expression was increased in fibroids compared to the adjacent myometrium samples. However, β-catenin expression showed no correlation with MED12 mutation status. Of all the WNT signaling components, WNT inhibitors showed the greatest differences in expression between fibroids and controls. WIF1, a WNT inhibitor, was identified as the most significantly upregulated gene in fibroids. We cultured primary fibroid cells on hydrogels of known stiffness to decipher the influence of biomechanical cues on β-catenin expression and revealed increased levels of β-catenin when cells were cultured on a stiffer surface. In conclusion, our data showed that β-catenin expression in fibroids occurs independently of MED12 mutations. Biomechanical changes upregulate β-catenin expression in fibroids, providing an attractive avenue for developing new treatments for this disease.
24
The Frequency of Uterine Leiomyomas
Stewart F. Cramer, Arti Patel · American Journal of Clinical Pathology · 1990 · 1.1K citations
Medicine, Gynecology, Pathology +12
Characterization of Uterine Leiomyomas by Whole-Genome Sequencing
Miika Mehine, Eevi Kaasinen, Netta Mäkinen et al. · New England Journal of Medicine · 2013 · 347 citations · Full text
Mediator Is a Transducer of Wnt/β-Catenin Signaling
Seokjoong Kim, Xuan Xu, Andreas Hecht et al. · Journal of Biological Chemistry · 2006 · 284 citations · Full text